Plan For NCHGR Receives Mixed Reaction

An initiative is under way to make the center an NIH institute; critics, however, argue that unnecessary redundancy would result. The National Center for Human Genome Research (NCHGR), which directs the National Institutes of Health's part in the Human Genome Project (HGP), is poised to become an institute. The necessary steps to change the center's status are already in motion, according to director Francis Collins, who supports the move. PROS AND CONS: Supporters note progress in NIH̵

Written bySteven Benowitz
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share


An initiative is under way to make the center an NIH institute; critics, however, argue that unnecessary redundancy would result.
The National Center for Human Genome Research (NCHGR), which directs the National Institutes of Health's part in the Human Genome Project (HGP), is poised to become an institute. The necessary steps to change the center's status are already in motion, according to director Francis Collins, who supports the move.

PROS AND CONS: Supporters note progress in NIH’s Human Genome Project under the direction of Francis Collins; critics, however, question some of his actions. NIH officials say the status change would not make much difference in authority or power. While most centers and institutes may differ substantially in their structure and research sponsorship capabilities, "NCHGR essentially has the same authority as an institute already," comments Diane Wax, NIH associate director for legislative policy and analysis. Becoming an institute "is probably a ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies